Clinical Trial Update: Retinal Structural and Functional Changes in Patients Treated With BRAF/MEK Inhibitors [NA]

View source ↗

Summary

Completed clinical trial update describing retinal structural and functional changes in patients treated with BRAF/MEK inhibitors. The report highlights MEK inh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma
• Retinopathy Mek Inhibitor-associated

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Malignant Melanoma, MEK Inhibitor-Associated Retinopathy | NA | Status: COMPLETED